You are here

Project Development

Projects with translational potential are guided through the commercialisation process by one of CRT’s experienced Business Development Managers. We work with academic institutes and industrial partners of all sizes and can identify the most suitable development routes for a project or portfolio.

Our team maintains a strong relationship and direct lines of communication with the originating scientist while we aim to secure and manage the most appropriate commercial deal for a project.

CRT completes around 50 licensing or collaboration agreements each year. Our services include:

PROJECT IDENTIFICATION Open

CRT Business Development Managers proactively work with research scientists, as they are undertaking their research, to identify possible new discoveries with strong clinical and commercial potential.

A rigorous and well-defined internal evaluation process is designed to determine if an invention can be protected and to identify the most suitable routes to get new cancer therapies and diagnostics to market.

PROTECTING MATERIALS Open

It is important for scientists to protect the materials and information they share with other scientists. CRT can advise on and prepare Material Transfer Agreements, Confidentiality Disclosure Agreements, and Consultancy Agreements. Non-published data, ideas, inventions and other confidential information can constitute valuable intellectual property and should also be protected prior to publication.

Learn more about protecting your materials.

PATENT FILING Open

The filing of a patent application is the most common way to protect an invention. CRT has extensive experience in filing, managing and commercialising patent applications.

We appreciate that finding the resources to fund the up-front costs of filing and prosecuting patent applications can pose problems for scientists and research institutions. We therefore cover these costs, only recouping our outlay if we are successful in securing a commercial partner committed to funding further development of the project. We also:

  • Liaise with scientists and patent law firms to ensure that high quality applications are filed.
  • Evaluate, together with the inventors, the patentability and commercial potential of the invention.
  • Assist in resolving questions regarding ownership and inventorship of IP.

PROJECT DEVELOPMENT Open

Projects are comprehensively reviewed to expand and deepen the understanding around the initial invention and to enable the strongest clinical and market position to be established.

CRT Business Development Managers will usually propose a course of project development that may involve further experiments in the scientist's laboratory, or more industrial-orientated development work to add value to the invention. The Business Development Manager will recommend whether this should be undertaken within the host institution, in collaboration with a commercial partner or within CRT's Discovery Laboratories.

MARKETING Open

CRT has strong links with a wide range of international pharmaceutical and biotechnology companies and our Business Development team meets with more than 100 oncology companies annually to explore potential opportunities and synergies.

Through an assessment of the development needs of a project, awareness of what is happening in the oncology industry and knowledge of the particular strategic focus of different companies, CRT Business Development Managers can identify which commercial partners have the greatest likelihood of achieving clinical success and ultimately patient benefit from a scientist’s invention.

LICENSING AND PARTNERING Open

CRT Business Development Managers and our in-house legal team prepare high-quality, robust agreements that clearly define the expectations, intentions and obligations of all parties. A deal team is established who is experienced in structuring, negotiating and drafting a wide variety of agreements on behalf of our academic partners. This team proactively works to complete the deal.

POST-SIGNATURE MANAGEMENT Open

Most importantly, to ensure clinical success and patient benefit is achieved, CRT actively monitors and manages the project after agreement signature. This activity is vital to ensure that:

  • the licensee develops the project promptly and effectively;
  • each party meets its obligations;
  • appropriate revenue distribution is achieved;
  • advantage is taken of new information and developments, as they arise.
  • CRT Business Development Managers proactively work with research scientists, as they are undertaking their research, to identify possible new discoveries with strong clinical and commercial potential.

    A rigorous and well-defined internal evaluation process is designed to determine if an invention can be protected and to identify the most suitable routes to get new cancer therapies and diagnostics to market.

  • It is important for scientists to protect the materials and information they share with other scientists. CRT can advise on and prepare Material Transfer Agreements, Confidentiality Disclosure Agreements, and Consultancy Agreements. Non-published data, ideas, inventions and other confidential information can constitute valuable intellectual property and should also be protected prior to publication.

    Learn more about protecting your materials.

  • The filing of a patent application is the most common way to protect an invention. CRT has extensive experience in filing, managing and commercialising patent applications.

    We appreciate that finding the resources to fund the up-front costs of filing and prosecuting patent applications can pose problems for scientists and research institutions. We therefore cover these costs, only recouping our outlay if we are successful in securing a commercial partner committed to funding further development of the project. We also:

    • Liaise with scientists and patent law firms to ensure that high quality applications are filed.
    • Evaluate, together with the inventors, the patentability and commercial potential of the invention.
    • Assist in resolving questions regarding ownership and inventorship of IP.
  • Projects are comprehensively reviewed to expand and deepen the understanding around the initial invention and to enable the strongest clinical and market position to be established.

    CRT Business Development Managers will usually propose a course of project development that may involve further experiments in the scientist's laboratory, or more industrial-orientated development work to add value to the invention. The Business Development Manager will recommend whether this should be undertaken within the host institution, in collaboration with a commercial partner or within CRT's Discovery Laboratories.

  • CRT has strong links with a wide range of international pharmaceutical and biotechnology companies and our Business Development team meets with more than 100 oncology companies annually to explore potential opportunities and synergies.

    Through an assessment of the development needs of a project, awareness of what is happening in the oncology industry and knowledge of the particular strategic focus of different companies, CRT Business Development Managers can identify which commercial partners have the greatest likelihood of achieving clinical success and ultimately patient benefit from a scientist’s invention.

  • CRT Business Development Managers and our in-house legal team prepare high-quality, robust agreements that clearly define the expectations, intentions and obligations of all parties. A deal team is established who is experienced in structuring, negotiating and drafting a wide variety of agreements on behalf of our academic partners. This team proactively works to complete the deal.

  • Most importantly, to ensure clinical success and patient benefit is achieved, CRT actively monitors and manages the project after agreement signature. This activity is vital to ensure that:

    • the licensee develops the project promptly and effectively;
    • each party meets its obligations;
    • appropriate revenue distribution is achieved;
    • advantage is taken of new information and developments, as they arise.